Granulomatosis with polyangiitis and facial palsy: Literature review and insight in the autoimmune pathogenesis

Autoimmunity Reviews

Volumn 15, Issue 7, 2016, Pages 621-631

  Iannella, Giannicola ^a   Greco, Antonio ^a   Granata, Guido ^a   Manno, Alessandra ^a   Pasquariello, Benedetta ^a   Angeletti, Diletta ^a   Didona, Dario ^b   Magliulo, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

ANCA associated vasculitis; Autoimmune facial palsy; Facial nerve; Facial palsy; Granulomatosis with polyangiitis; Wegener's granulomatosis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNITY; CLINICAL FEATURE; DISEASE COURSE; FACIAL NERVE PARALYSIS; HISTOPATHOLOGY; HUMAN; NECROTIZING ARTERITIS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SMALL VESSEL VASCULITIS; VASA NERVORUM; WEGENER GRANULOMATOSIS; ANCA ASSOCIATED VASCULITIS; ANIMAL; BELL PALSY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BELL PALSY; DISEASE PROGRESSION; FACIAL PARALYSIS; GRANULOMATOSIS WITH POLYANGIITIS; HUMANS;

EID: 84962069473     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.02.005     Document Type: Review

References (97)

1. Lutalo P.M., D'Cruz D.P. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). J Autoimmun 2014, 48-49:94-98.
2. Comarmond C., Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 2014, 13:1121-1125.
3. Guidelli G.M., Tenti S., Pascarelli N.A., Galeazzi M. Fioravanti A. Granulomatosis with polyangiitis and intravenous immunoglobulins: a case series and review of the literature. Autoimmun Rev 2015, 14:659-664.
4. Jennette J.C. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Exp Immunol 2011, 164:7-10.
5. Falk R.J., Gross W.L., Guillevin L., et al. American College of Rheumatology; American Society of Nephrology; European League Against Rheumatism. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 2011, 63:863-864.
6. Scott D.G., Watts R.A. Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 2000, 59:161-163.
7. Cartin-Ceba R., Peikert T., Specks U. Pathogenesis of ANCA-associated vasculitis. Curr Rheumatol Rep 2012, 14:481-493.
8. Land J., Rutgers A., Kallenberg C.G. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody. Nephrol Dial Transplant 2014, 29:739-745.
9. Kallenberg C.G., Rarok A., Stegeman C.A., Limburg P.C. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis. Autoimmun Rev 2002, 1:61-66.
10. Falk R.J., Terrell R.S., Charles L.A., Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990, 87:4115-4119.
11. Reumaux D., Vossebeld P.J., Roos D., Verhoeven A.J. Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 1995, 86:3189-3195.
12. Brouwer E., Huitema M.G., Mulder A.H., et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int 1994, 45:1120-1131.
13. Porges A.J., Redecha P.B., Kimberly W.T., et al. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994, 153:1271-1280.
14. Kettritz R., Jennette J.C., Falk R.J. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 1997, 8:386-394.
15. Daouk G.H., Palsson R., Arnaout M.A. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 1995, 47:1528-1536.
16. Dolman K.M., Jager A., Sonnenberg A., von dem Borne A.E., Goldschmeding R. Proteolysis of classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) by neutrophil proteinase 3. Clin Exp Immunol 1995, 101:8-12.
17. Dolman K.M., Stegeman C.A., van de Wiel B.A., et al. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp Immunol 1993, 93:405-410.
18. Leavitt R.Y., Fauci A.S., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990, 33:1101-1107.
19. Bloch D.A., Michel B.A., Hunder G.G., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. Arthritis Rheum 1990, 33:1068-1073.
20. Lembicz M., Batura-Gabryel H., Nowicka A. Granulomatosis with polyangiitis-clinical picture and review of current treatment options. Pneumonol Alergol Pol 2014, 82:61-73.
21. Schilder A.M. Wegener's granulomatosis vasculitis and granuloma. Autoimmun Rev 2010, 9:483-487.
22. Morales-Angulo C., García-Zornoza R., Obeso-Agüera S., Calvo-Alén J., González-Gay M.A. Ear, nose and throat manifestations of Wegener's granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp 2012, 63:206-211.
23. Parra-García G.D., Callejas-Rubio J.L., Ríos-Fernández R., Sainz-Quevedo M., Ortego-Centeno N. Otolaryngologic manifestations of systemic vasculitis. Acta Otorrinolaringol Esp 2012, 63:303-310.
24. Trimarchi M., Sinico R.A., Teggi R., Bussi M., Specks U., Meroni P.L. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener's). Autoimmun Rev 2013, 12:501-505.
25. Tsuzuki K., Fukazawa K., Takebayashi H., Hashimoto K., Sakagami M. Difficulty of diagnosing Wegener's granulomatosis in the head and neck Region. Auris Nasus Larynx 2009, 36:64-70.
26. Yoshida N., Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int 2014, 63:523-532.
27. Magliulo G., Varacalli S., Sepe C. Wegener's granulomatosis presenting as facial palsy. Am J Otolaryngol 1999, 20:43-45.
28. Magliulo G., Parrotto D., Alla F.R., Gagliardi S. Acute bilateral facial palsy and Wegener's disease. Otolaryngol Head Neck Surg 2008, 139:476-477.
29. Nicklasson Nicklassonv B., Stangeland N. Wegener's granulomatosis presenting as otitis media. J Laryngol Otol 1982, 96:277-280.
30. Wierzbicka M., Puszczewicz M., Bartochowska A., Szyfter W. The otologic manifestation of Wegener's granulomatosis-review of contemporary achievements in diagnostics and treatment. Otolaryngol Pol 2012, 66:254-258.
31. Wierzbicka M., Szyfter W., Puszczewicz M., Borucki L., Bartochowska A. Otologic symptoms as initial manifestation of Wegener granulomatosis: diagnostic dilemma. Otol Neurotol 2011, 32:996-1000.
32. Yoshida N., Hara M., Hasegawa M., et al. Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms. Otol Neurotol 2014, 35:114-120.
33. Santos F., Salviz M., Domond H., Nadol J.B. Otopathology of vasculitis in granulomatosis with polyangitis. Otol Neurotol 2015, 36:1657-1662.
34. Magliulo G., Ciniglio Appiani M., Porcaro M., Iannella G. Pneumolabyrinth following eustachian tube insufflation. Otolaryngol Head Neck Surg 2012, 147:980-981.
35. Rasmussen N. Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective. Curr Opin Rheumatol 2001, 13:3-11.
36. Drinias V., Florentzson R. Facial palsy and Wegener's granulomatosis. Am J Otolaryngol 2004, 25:208-212.
37. Greco A., Gallo A., Fusconi M., Marinelli C., Macri G.F., de Vincentiis M. Bell's palsy and autoimmunity. Autoimmun Rev 2012, 12:323-328.
38. Magliulo G., Zardo F. Intra-operative facial nerve monitoring. Its predictive value after skull base surgery. J Laryngol Otol 1997, 111:715-718.
39. Magliulo G., Petti R., Vingolo G.M., Ronzoni R., Cristofari P. Facial nerve monitoring of skull base and cerebellopontine angle lesions. Eur Arch Otorhinolaryngol 1994, 314-5.
40. Magliulo G., Petti R., Vingolo G.M., Cristofari P., Ronzoni R. Facial nerve monitoring in skull base surgery. J Laryngol Otol 1994, 108:557-559.
41. Magliulo G., Zardo F. Facial nerve function after cerebellopontine angle surgery and prognostic value of intraoperative facial nerve monitoring: a critical evaluation. Am J Otolaryngol 1998, 19:102-106.
42. Ciofalo A., Zambetti G., Romeo M., et al. Taste and olfaction in middle ear surgery. Ann Otol Rhinol Laryngol 2015, 124:312-316.
43. Fattah A.Y., Gurusinghe A.D., Gavilan J., et al. Facial nerve grading instruments: systematic review of the literature and suggestion for uniformity. Plast Reconstr Surg 2015, 135:569-579.
44. Magliulo G., D'Amico R., Forino M. Results and complications of facial reanimation following cerebellopontine angle surgery. Eur Arch Otorhinolaryngol 2001, 258:45-48.
45. Calonius I.H., Christensen C.K. Hearing impairment and facial palsy as initial signs of Wegener's granulomatosis. J Laryngol Otol 1980, 94:649-657.
46. Macias J.D., Wackym P.A., McCabe B.F. Early diagnosis of otologic Wegener's granulomatosis using the serologic marker C-ANCA. Ann Otol Rhinol Laryngol 1993, 102:337-341.
47. Hern J.D., Hollis L.J., Mochloulis G., Montgomery P.Q., Tolley N.S. Early diagnosis of Wegener's granulomatosis presenting with facial nerve palsy. J Laryngol Otol 1996, 110:459-461.
48. Dagum P., Roberson J.B. Otologic Wegener's granulomatosis with facial nerve palsy. Ann Otol Rhinol Laryngol 1998, 107:555-559.
49. Hartl D.M., Aïdan P., Brugière O., Sterkers O. Wegener's granulomatosis presenting as a recurrence of chronic otitis media. Am J Otolaryngol 1998, 19:54-60.
50. Hofmann T., Kainz J., Koc C., Smolle K.H., Brunner G. Isolated unilateral otitis with facial nerve paralysis as initial symptom of Wegener granulomatosis. An unusual clinical course. Laryngorhinootologie 1998, 77:352-354.
51. Ohtani I., Baba Y., Suzuki C., Sakuma H., Kano M. Temporal bone pathology in Wegener's granulomatosis. Fukushima J Med Sci 2000, 46:31-39.
52. Bibas A., Fahy C., Sneddon L., Bowdler D. Facial paralysis in Wegener's granulomatosis of the middle ear. J Laryngol Otol 2001, 115:304-306.
53. Banerjee A., Armas J.M., Dempster J.H. Wegener's granulomatosis: diagnostic dilemma. J Laryngol Otol 2001, 115:46-47.
54. Nikolaou A.C., Vlachtsis K.C., Daniilidis M.A., Petridis D.G., Daniilidis I.C. Wegener's granulomatosis presenting with bilateral facial nerve palsy. Eur Arch Otorhinolaryngol 2001, 258:198-202.
55. Keni S.P., Wiley E.L., Dutra J.C., Mellott A.L., Barr W.G., Altman K.W. Skull base Wegener's granulomatosis resulting in multiple cranial neuropathies. Am J Otolaryngol 2005, 26:146-149.
56. Ferri E., Armato E., Capuzzo P., Cavaleri S., Ianniello F. Early diagnosis of Wegener's granulomatosis presenting with bilateral facial paralysis and bilateral serous otitis media. Auris Nasus Larynx 2007, 34:379-382.
57. Kloeck I., Crols R., De Belder T., Vandist V., Schmelzer B. Wegener's granulomatosis presenting as otomastoiditis. A case report. B-ENT 2006, 2:7-12.
58. Wang J., Xiao S.F., Qin Y., Wang Q.G., Chen L. A case of facial palsy as a initial sign of Wegener's granulomatosis. Beijing Da Xue Xue Bao 2007, 39:434-436.
59. Tesche S., Münscher A., Metternich F.U. Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy. Laryngorhinootologie 2007, 86:775-779.
60. Preuss S.F., Stenner M., Beutner D., Laudes M., Klussmann J.P. Fatal course of Wegener's granulomatosis with bilateral otomastoiditis and bilateral facial nerve palsy. Otolaryngol Head Neck Surg 2008, 138:799-800.
61. Shiva Prasad B.N., Balasubramanian R. Chronic otitis media and facial paralysis as a presenting feature of Wegener's granulomatosis. Singapore Med J 2009, 50:155-157.
62. Bohne S., Koscielny S., Burmeister H.P., Guntinas-Lichius O., Wittekindt C. Bilateral deafness and unilateral facial nerve palsy as presenting features of Wegener's granulomatosis: a case report. HNO 2010, 58:480-483.
63. Madhira S., Hamid Q.A., Prayaga S.M., Kolloju S. Limited Wegener's granulomatosis with predominant otological presentation. Indian J Otolaryngol Head Neck Surg 2011, 63:4-5.
64. Sharma A., Deshmukh S., Shaikh A., Dabholkar J. Wegener's granulomatosis mimicking skull base osteomyelitis. J Laryngol Otol 2012, 126:203-206.
65. Maranhão A.S., Chen V.G., Rossini B.A., Testa J.R., Penido Nde O. Mastoiditis and facial paralysis as initial manifestations of Wegener's granulomatosis. Braz J Otorhinolaryngol 2012, 78:80-86.
66. Sharma A., Deshmukh S., Dabholkar J. ENT manifestations of Wegeners granulomatosis. Otolaryngol Pol 2013, 67:257-260.
67. Gómez-Torres A., Tirado Zamora I., Abrante Jiménez A., Esteban Ortega F. Wegener's granulomatosis causing bilateral facial paralysis and deafness. Acta Otorrinolaringol Esp 2013, 64:154-156.
68. Rajiv K.R., Balaji G., Nagabushan M.V., Reddy Y.J. Bilateral otitis media, dacroadenitis, parotitis and left sided infranuclear facial palsy: unusual manifestations of Wegener's granulomatosis. J Assoc Physicians India 2013, 61:922-925.
69. Hobson C.E., Chiosea S., Mohan N., McCall A.A. Pathology quiz case 3: Wegener granulomatosis. JAMA Otolaryngol Head Neck Surg 2013, 139:533-535.
70. Mori A., Hira K., Hatano T., Okuma Y., et al. Bilateral facial nerve palsy due to otitis media associated with myeloperoxidase-antineutrophil cytoplasmic antibody. Am J Med Sci 2013, 346:240-243.
71. Lee J.H., Kim K.W., Myong N.H., Jung J.Y. Wegener's granulomatosis presenting as bilateral otalgia with facial palsy: a case report. Korean J Audiol 2013, 17:35-37.
72. Roszkowska A., Morawska-Kochman M., Temporale H., Sikorska-Žuk M., Krecicki T. Bilateral facial palsy in rapidly progressive course of Wegener's granulomatosis: a case report. Case Rep Otolaryngol 2013, 2013:875108.
73. Kristin J., Beutner C., Klenzner T., Knapp F.B. Granulomatosis with polyangiitis and multiple bilateral cranial nerve palsies: a diagnostic challenge. B-ENT 2014, 10:231-235.
74. Amiraraghi N., Robertson S., Iyer A. Primary otological manifestations of granulomatosis with polyangiitis: a case series. J Laryngol Otol 2015, 129:179-182.
75. Martinez Del Pero M., McKiernan D., Jani P. Presentation and initial assessment of ENT problems in patients with granulomatosis with polyangiitis (Wegener's). J Laryngol Otol 2014, 128:730-737.
76. Thornton M.A., O'Sullivan T.J. Otological Wegeners granulomatosis: a diagnostic dilemma. Clin Otolaryngol Allied Sci 2000, 25:433-434.
77. Magliulo G., Colicchio M.G., Appiani M.C. Facial nerve dehiscence and cholesteatoma. Ann Otol Rhinol Laryngol 2011, 120:261-267.
78. Magliulo G., Celebrini A., Cuiuli G., Parrotto D. Surgical management of the labyrinthine fistula complicating chronic otitis media with or without cholesteatoma. J Otolaryngol Head Neck Surg 2008, 37:143-147.
79. Magliulo G. Petrous bone cholesteatoma: clinical longitudinal study. Eur Arch Otorhinolaryngol 2007, 264:115-120.
80. Magliulo G., Terranova G., Sepe C., Cordeschi S., Cristofar P. Petrous bone cholesteatoma and facial paralysis. Clin Otolaryngol Allied Sci 1998, 23:253-258.
81. Kallenberg C.G., Stegeman C.A., Abdulahad W.H., Heeringa P. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Am J Kidney Dis 2013, 62:1176-1187.
82. Kallenberg C.G. Advances in pathogenesis and treatment of ANCA-associated vasculitis. Discov Med 2014, 18:195-201.
83. Yoon T.H., Paparella M.M., Schachern P.A. Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 1989, 99:600-609.
84. Joglekar S., Deroee A.F., Morita N., et al. Polyarteritis nodosa: a human temporal bone study. Am J Otolaryngol 2010, 31:221-225.
85. Lamprecht P., Holle J., Gross W.L. Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitides. Curr Drug Discov Technol 2009, 6:241-251.
86. Lamprecht P., Brühl H., Erdmann A., et al. Differences in CCR5 expression on peripheral blood CD4 + CD28- T cells and in granulomatous lesions between localized and generalized Wegener's granulomatosis. Clin Immunol 2003, 108:1-7.
87. Yilmaz M., Tarakcioglu M., Bayazit N., Bayazit Y.A., Namiduru M., Kanlikama M. Serum cytokine levels in Bell's palsy. J Neurol Sci 2002, 197:69-72.
88. Sneller M.C. Granuloma formation, implications for the pathogenesis of vasculitis. Cleve Clin J Med 2002, 69:40-43.
89. Aviel A., Ostfeld E., Burstein R., Marshak G., Bentwich Z. Peripheral blood T and B lymphocyte subpopulations in Bell's palsy. Ann Otol Rhinol Laryngol 1983, 92:187-191.
90. Abramsky O., Webb C., Teitelbaum D., Arnon R. Cellular immune response to peripheral nerve basic protein in idiopathic facial paralysis (Bell's palsy). J Neurol Sci 1975, 26:13-20.
91. Mañós-Pujol M., Buendia E., Mestre M., Jimenéz R., Gil E., Menén J.P., et al. Cellular immunity abnormalities in patients with recurrent Bell's palsy. Clin Otolaryngol 1987, 12:283-287.
92. Bosch X., Guilabert A., Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006, 368:404-418.
93. Smith R.M. Update on the treatment of ANCA associated vasculitis. Presse Med 2015, 44:241-249.
94. Magliulo G., Iannella G., Ciniglio Appiani M., Re M. Unilateral vestibular schwannoma associated with a Jacobson's schwannoma. Eur Rev Med Pharmacol Sci 2014, 18:1422-1425.
95. Magliulo G., Varacalli S., Ciofalo A. Osteomyelitis of the skull base with atypical onset and evolution. Ann Otol Rhinol Laryngol 2000, 109:326-330.
96. Holle J.U., Gross W.L. Treatment of ANCA-associated vasculitides (AAV). Autoimmun Rev 2013, 12:483-486.
97. Takagi D., Nakamaru Y., Maguchi S., Furuta Y., Fukuda S. Otologic manifestations of Wegener's granulomatosis. Laryngoscope 2002, 112:1684-1690.